6Ling KL, regulatory lymphocytes 7: 7. Pratap SE, Bates GJ, etal. Increased frequency of T ceils in peripheral blood and tumor infiltrating in colorectal cancer patients[J]. Cancer Immun, 2007.
7Lau KM, Cheng SH. Lo kW, et al. Increase in circulating Foxp3+ CD4+ (3)25 (high) regulatory T cells in nasopharyngeal careinoma patients[J]. Br J Cancer, 2007, 96(4) : 617-622.
1Enarsson K, Lundin BS, Johnsson E, et al. CD4 + CD25 high regulatory T cells reduce T cell transendothelial migration in cancer patients[J]. Eur J Immunol, 2007, 37( 1 ) :282-291.
2Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases [ J ], J Immunol, 1995, 155(3) :1151-1164.
3Jonuleit H, Schmitt E, Stassen M, et al. Identification and functional characterization of human CD4^+CD25^+ T cells with regulatory properties isolated from peripheral blood [ J ]. J Exp Med,2001, 193 ( 11 ) : 1285-1294.
4Seo N, Hayakawa S, Takigawa M, et al. Interleukin-10 expressed at early tumor sites induces subsequent generation of CD4 ( + ) T- regulatory cells and systemic collapse of antitumor immunity [ J ]. Immunology, 2001, 103(4) :449-457.
5Ling KL, Pratap SE, Bates GJ, et al. Increased frequency of regulatory T cells in peripheral blood and tumor infiltrating lymphocytes in colorectal cancer patients[ J]. Cancer Immun, 2007, 7 : 7.
6Leong PP, Mohammad R, Ibrahim N, et al. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast [ J]. Immunol Lett, 2006, 102 (2) :229-236.
7Lau KM, Cheng SH, Lo KW, et al. Increase in circulating Foxp3 + CD4 + CD25 (high) regulatory T cells in nasopharyngeal carcinoma patients[ J]. Br J Cancer, 2007, 96(4) :617-622.
8Chen ML, Pittet MJ, Gorelik L, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo[J]. Proc Natl Acad Sci USA, 2005, 102(2) :419-424.
9Imai H, Saio M, Nonaka K, et al. Depletion of CD4+ CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma[ J]. Cancer Sci, 2007, 98(3) :416-423.
